Date: 2015-08-24
Type of information: Nomination
Compound:
Company: Amag Pharmaceuticals (USA - MA)
Therapeutic area:
Type agreement: nomination
Action mechanism:
Disease:
Details: * On August 24, 2015, AMAG Pharmaceuticals announced that Joseph Vittiglio has joined the company as senior vice president, general counsel and secretary. In this position, Mr. Vittiglio will oversee all legal affairs of the company. Mr. Vittiglio has more than 18 years of legal and operations experience counseling biopharmaceutical and specialty pharmaceutical companies in product development, commercialization and launch, corporate finance and partnering transactions, governance and litigation. He most recently served as vice president of legal affairs and a member of the management committee at Flexion Therapeutics. From 2007 to 2015, Mr. Vittiglio served as general counsel of AVEO Pharmaceuticals. Prior to that, Mr. Vittiglio served as director of legal affairs at Oscient Pharmaceuticals. Mr. Vittiglio holds a bachelor\'s degree in international relations from Tufts University and a juris doctor from Northeastern University School of Law. In connection with Mr. Vittiglio\'s entering into employment with AMAG, the Board of Directors of AMAG approved awards to Mr. Vittiglio of (i) an option to purchase 30,000 shares of common stock and (ii) 15,000 restricted stock units. The option will have an exercise price equal to the closing price of AMAG\'s common stock on the grant date and will be exercisable in four equal annual installments beginning on the first anniversary of the grant date. The option will have a ten-year term and be subject to the terms and conditions of the stock option agreement pursuant to which the option will be granted. The restricted stock units will vest in three equal annual installments beginning on the first anniversary of the grant date and will be subject to the restricted stock unit agreement pursuant to which the restricted stock units will be granted. These equity awards will be granted without stockholder approval as inducements material to Mr. Vittiglio entering into employment with AMAG in accordance with NASDAQ Listing Rule 5635(c)(4).
Financial terms:
Latest news:
